Table 2

Relationship between serum adiponectin levels and breast cancer risk

Adiponectin level (μg/ml)Cases Number (%)Controls Number (%)OR (95% CI)aOR (95% CI)b
All cases
 >10.617 (17)33 (33)1.001.00
 >6.9, ≤10.636 (35)33 (33)2.29 (1.06–4.94)c2.79 (1.23–6.35)c
 ≤6.949 (48)34 (34)2.87 (1.38–5.98)d3.63 (1.61–8.19)e
Premenopausal
 >10.66 (12)12 (27)1.001.00
 >6.9, ≤10.625 (48)16 (36)3.08 (0.96–9.88)f3.41 (0.99–11.66)f
 ≤6.921 (40)17 (38)2.35 (0.71–7.72)3.46 (0.89–13.50)f
Postmenopausal
 >10.611 (22)21 (38)1.001.00
 >6.9, ≤10.611 (22)17 (31)1.62 (0.53–4.97)1.94 (0.51–7.44)
 ≤6.928 (56)17 (31)3.95 (1.43–10.92)d3.90 (1.23–12.44)c
  • a Adjusted for age.

  • b Adjusted for age, family history, age at menarche, parity, BMI, and age at menopause for postmenopausals.

  • c P < 0.05.

  • d P < 0.01.

  • e P < 0.005.

  • f P < 0.10.